Academics
Admissions & Aid
Student Life
About
Info For
The Brooklyn College Emergency Medical Squad is committed to providing a safe and healthful work environment for our entire staff. In pursuit of this endeavor, the following Exposure Control Plan (ECP) is provided to eliminate or minimize occupational exposure to blood-borne pathogens in accordance with OSHA Blood-borne Pathogens Standard, Title 29 Code of Federal Regulations 1910.1030.
The ECP is a key document to assist our squad in implementing and ensuring compliance with this standard, thereby protecting our volunteers. This ECP includes:
The administrator and chief of operations are responsible for the implementation of the ECP. They will maintain and update the written ECP at least annually and whenever necessary to include new and modified tasks and procedures. Members who are reasonably anticipated to have contact with exposure to blood and other potentially infected materials are required to comply with the procedures and work practices outlined in this ECP. The house officer will have the responsibility for written housekeeping protocols and will ensure that effective disinfectants are purchased. The administrator will be responsible for training, documentation of training, and making the written ECP available to members, OSHA and NIOSH representatives. The equipment officer will maintain and provide all necessary personal protective equipment (PPE), sharps containers, labels and red bags as required by the standard. He or she will ensure that adequate supplies of the aforementioned equipment are available.
As part of the exposure determination section of our ECP, the following is a list of job classifications where squad members may have an occupational exposure:
All exposure determinations for A and B were made without regard to the use of PPE.
As of March 6, 1992, all members will utilize Universal Precautions. Universal Precautions is an infection-control method that requires members to assume that all human blood and specified human body fluids are infectious for HIV, HBV, and other blood-borne pathogens and must be treated accordingly.
Members covered by the Blood-borne Pathogens Standard will receive an explanation of this ECP during their training sessions. It will also be reviewed in their annual refresher training. All members will have the opportunity to review this plan at any time during their work shift by contacting the administrator or chief of operations. A copy of the plan will be made available free of charge and within 15 days of the request.
The administrator and chief of operations will also be responsible for reviewing and updating the ECP annually or sooner if necessary to reflect any new or modified tasks and procedures which affect occupational exposure and to reflect new or revised employee positions with occupational exposure.
Engineering controls and work practice controls will be used to prevent or minimize exposure to blood-borne pathogens. The specific engineering controls and workplace controls we will use are:
Engineering controls (sharp’s containers, etc.) will be inspected once a week by the equipment officer.
Work practice controls include, but are not limited to:
PPE must also be used if occupational exposure remains after instituting engineering and work practice controls, or controls are not feasible. The training officer in the use of PPE will provide training. Appropriate equipment/Universal Precautions are required in the following tasks:
As a general rule, all members using PPE must observe the following precautions:
All members who have reasonably anticipated having occupational exposure to blood-borne pathogens will receive training by the administrator or training officer. The trainer will provide training on the epidemiology of blood-borne pathogen diseases. OSHA regulations on “Workers Exposure to AIDS and Hepatitis B” will be included in all training. In addition, training will include the following materials:
A Member Education and Training Record will be completed for each employee upon completion of training. This document will be kept with the membership records in 1407 Boylan Hall.
The administrator or training officer will provide information on the Hepatitis B vaccination (HBV), addressing its safety, benefits, efficacy, methods of administration and availability. The HBV series will be made available at no cost to members who have occupational exposure to blood or other potentially infectious materials.
The following members are exempt from receiving the HBV:
All members are strongly encouraged to receive the HBV series. However, if any member chooses to decline the HB vaccine, that member must sign a statement to this effect. Members who decline may request and obtain the vaccination at a latter date at no cost. Documentation of refusal of the HBV series will be kept in 1407 Boylan Hall with the members’ other records.
Any member who begins but fails to complete the HB Vaccination series will be entitled to restart the series at cost to the member.
Should an exposure incident occur, contact the administrator or chief of operations immediately. Each exposure must be documented by the member on an Exposure Report Form. An immediately available confidential medical evaluation and follow up will be conducted by a hospital emergency department. The following steps will be taken:
If the member does not give consent for HIV serological testing during the collection of blood for baseline testing, preserve the blood for at least 90 days
If, during this time the exposed member elects to have the baseline blood tested, testing must be performed as soon as feasible
The administrator will review the circumstances of the exposure incident to determine if procedures, protocols and/or training need to be revised.
The administrator will ensure that health care professionals responsible for members’ HB vaccination and post-exposure evaluation and follow up be given a copy of the OSHA Blood-borne Standard. The administrator will also ensure that the health care professional evaluating an employee after an exposure incident receives the following:
The administrator will provide the member with a copy of the evaluating health care professional’s written opinion within 15 days after completion of the evaluation. For HB vaccinations, the health care professional’s written opinion will be limited to whether the member requires or has received HB vaccinations. The written opinion for post-exposure evaluation and follow-up will be limited to whether or not the member has been informed of the results of the medical evaluation and any medical conditions that may require further evaluation and treatment. All other diagnoses must remain confidential and not be included in the written report to our squad.
Medical records are maintained for each member with occupational exposure in accordance with 29 CFR 1910.20. The administrator is responsible for maintenance of the medical records. In addition to the requirements of 29 CFR 1910.20, the medical records will include:
All member medical records will be kept confidential and will not be disclosed or reported without the employee’s express written consent to any person within or outside the college except as required by the standard or as may be required by law. Member medical records shall be maintained for at least the duration of membership plus 30 years, in accordance with the standard. Members’ medical record shall be provided upon request of the member or to anyone with written consent of the member within 15 working days.
The training officer or administrator will maintain blood-borne pathogen-training records. The training record shall include:
Training records will be maintained for a minimum of three years from the date on which the training occurred. Members’ training records will be provided upon request to the member or the member’s authorized representative within 15 working days.
If BC-EMS and Brooklyn College cease to exist, the squad shall notify the director of the National Institute for Occupational Safety and Health (NIOSH) at least three months prior to scheduled record disposal and prepare to transmit them to the director.
Hepatitis B virus is a potentially life-threatening blood-borne pathogen. The Centers for Disease Control estimates there are approximately 280,000 infections each year in the United States.
Approximately 8,700 health care workers each year contract hepatitis B, and about 200 will die as a result. In addition, some who contract hepatitis B will become carriers, passing the disease on to others. Carriers also face a significantly higher risk for other liver ailments, which can be fatal, including cirrhosis of the liver and primary liver cancer.
Hepatitis B virus infection is transmitted through exposure to blood and other infectious body fluids and fissures. Anyone with occupational exposure to blood is at risk of contracting the infection.
Employers must provide engineering controls; workers must use work practices and protective clothing and equipment to prevent exposure to potentially infectious materials. However, the best defense against hepatitis B is vaccination.
The new OSHA standard covering blood-borne pathogens requires employers to offer the three-injection vaccination series free to all employees who are exposed to blood or other potentially infectious materials as part of their job duties. This includes health care workers, emergency responders, morticians, first-aid personnel, law enforcement officers, correctional facilities staff and launderers.
The vaccination must be offered within 10 days of initial assignment to a job where exposure to blood or other potentially infectious materials can be “reasonably anticipated.” The requirements for vaccinations of those already on the job take effect July 6, 1992.
The hepatitis B vaccination is a noninfectious, yeast-based vaccine given in three injections in the arm. It is prepared from recombinant yeast cultures, rather than human blood or plasma. Thus, there is no risk of contamination from other blood-borne pathogens nor is there any chance of developing the virus from the vaccine.
The second injection should be given one month after the first, and the third injection six months after the initial dose. More than 90 percent of those vaccinated will develop immunity to the hepatitis B virus. To ensure immunity, it is important for individuals to receive all three injections. At this point, it is unclear how long the immunity lasts, so booster shots may be required at some point in the future.
The vaccine causes no harm to those who are already immune or to those who may be virus carriers. Although employees may opt to have their blood tested for antibodies to determine need for the vaccine, employers may not make such screening a condition of receiving vaccination, nor are employers required to provide prescreening.
Each employee should receive counseling from a health care professional when vaccination is offered. This discussion will help an employee determine whether inoculation is necessary.
Workers who decide to decline vaccination must complete a declination form. Employers must keep these forms on file so that they know the vaccination status of everyone who is exposed to blood. At any time after a worker initially declines to receive the vaccine, he or she may opt to take it.
If a worker experiences an exposure incident, such as a needle stick or a blood splash in the eye, he or she must receive confidential medical evaluation from a licensed health care professional with appropriate follow-up. To the extent possible by law, the employer is to determine the source individual for the hepatitis B virus as well as human immunodeficiency virus (HIV) infectivity. The worker’s blood will also be screened if be or she agrees.
The health care professional is to follow the guidelines of the U.S. Public Health Service in providing treatment. This would include hepatitis B vaccination. The health care professional must give a written opinion on whether or not vaccination is recommended and whether the employee received it. Only this information is reported to the employer. Employee medical records must remain confidential. HIV or HB virus status must not be reported to the employer.